Sign in

Filings

Finds words inside filing documents. Searching Transcode Therapeutics, Inc.'s filings · 54 documents indexed.

20 documents · 48 matches

  1. RNAZ Transcode Therapeutics, Inc. 10-K 2026-04-15

    Item 1A. Risk Factors

    going concern without sufficient capital resources. Our independent registered public accounting firm included an explanatory paragraph in its report on our consolidated
    10 matches in this document

  2. RNAZ Transcode Therapeutics, Inc. 10-Q 2026-08-14

    Item 1. Financial Statements

    concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements
    5 matches in this document

  3. RNAZ Transcode Therapeutics, Inc. 10-Q 2026-05-15

    Item 1. Financial Statements

    concerning its ability to continue as a going concern within one year of the issuance of these consolidated financial statements
    4 matches in this document

  4. RNAZ Transcode Therapeutics, Inc. 10-Q 2025-11-14

    Item 1. Financial Statements

    concerning its ability to continue as a going concern within one year of the issuance of these financial statements without
    4 matches in this document

  5. RNAZ Transcode Therapeutics, Inc. 10-Q 2025-08-14

    Item 1. Financial Statements

    concerning its ability to continue as a going concern within one year of the issuance of these financial statements without
    4 matches in this document

  6. RNAZ Transcode Therapeutics, Inc. 10-Q 2025-05-14

    Item 1. Financial Statements

    concerning its ability to continue as a going concern within one year of the issuance of these financial statements without
    5 matches in this document

  7. RNAZ Transcode Therapeutics, Inc. 8-K/A 2025-12-23

    going concern for the next 12 months following the issuance date of these consolidated financial statements. Management's evaluation of the events
    3 matches in this document

  8. RNAZ Transcode Therapeutics, Inc. 8-K/A 2025-12-23

    going concern for the next 12 months following the issuance date of these consolidated financial statements. Management’s evaluation of the events
    1 match in this document

  9. RNAZ Transcode Therapeutics, Inc. 8-K 2026-09-28

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  10. RNAZ Transcode Therapeutics, Inc. 8-K 2026-06-03

    Item 8.01. Other Events.

    going concern; risks associated with the timing and outcome of TransCode's planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  11. RNAZ Transcode Therapeutics, Inc. 8-K 2026-06-03

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  12. RNAZ Transcode Therapeutics, Inc. 8-K 2026-04-07

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  13. RNAZ Transcode Therapeutics, Inc. 8-K 2026-03-03

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  14. RNAZ Transcode Therapeutics, Inc. 8-K 2026-02-23

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  15. RNAZ Transcode Therapeutics, Inc. 8-K 2026-02-05

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  16. RNAZ Transcode Therapeutics, Inc. 8-K 2026-01-06

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  17. RNAZ Transcode Therapeutics, Inc. 8-K 2025-12-22

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  18. RNAZ Transcode Therapeutics, Inc. 8-K 2025-12-11

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  19. RNAZ Transcode Therapeutics, Inc. 8-K 2025-10-14

    Item 8.01. Other Events.

    going concern; risks associated with the timing and outcome of TransCode's planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

  20. RNAZ Transcode Therapeutics, Inc. 8-K 2025-10-14

    going concern; risks associated with the timing and outcome of TransCode’s planned regulatory submissions; risks associated with obtaining, maintaining
    1 match in this document

Page 1 of 1 · 20 documents